Nycomed, Others Say Apotex Infringes Nasal Spray Patents
Nycomed GmbH, Teijin Pharma Ltd. and Sunovion Pharmaceuticals Inc., all of which play some role in the distribution of Omnaris, contend that Apotex's planned version of the allergy treatment violates three patents despite the generics maker's claims to the contrary.
The patents-in-suit are U.S. Patents Number...
To view the full article, register now.